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This report describes renal artery occlusion as a therapeutic 
alternative to nephrectomy and chemotherapy in treating 
patients with metastatic renal carcinoma. Using a combina-
tion of Gel foam and the Gianturco stainless steel coil, 
embolization was performed on 75 patients at the University 
of Texas System Cancer Center, M.D. Anderson Hospital and 
Tumor Institute with promising results. Its use is recom-
mended 7 jto facilitate surgical removal of large and difficult 
tumors, 2) to control local symptoms (pain, bleeding, etc), 
and 3) as part of a planned therapeutic program consisting 
of infarction, nephrectomy and progestins for patients with 
minimal to moderate metastatic disease. 
Because nephrectomy^ and chemotherapy^ have not sig-
nificantly improved the prognosis for patients with meta-
static renal carcinoma, there has been increased interest in 
renal artery occlusion as a therapeutic alternative. In the 
past, arterial embolization has been used for treating ar-
teriovenous malformations,^'" aneurysms,^ postbiopsy ar-
teriovenous renal fistulas,^ control of gastrointestinal and 
pelvic bleeding,'''^ and management of bone tumors. 
Almgard et aP^ were among the first to report promising 
results in the treatment of massive renal tumors by embolic 
occlusion of the larger renal vessels, and subsequent re-
ports^^"'"' have confirmed their findings. 
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Materials and Methods 
Although a variety of agents have been used to occlude the 
renal vessels (autogenous clot and tissue, Gelfoam, metal 
and plastic spheres, synthetic plastic compound, balloon 
catheters, and stainless steel coils), the technique developed 
at the University of Texas System Cancer Center, M.D. 
Anderson Hospital and Tumor Institute at Houston com-
bines Gelfoam"'^ and the Gianturco stainless steel coiP^"''^to 
occlude both the peripheral arterioles and the main renal 
artery. Initially, embolization was performed immediately 
after the diagnostic angiographic evaluation of the sus-
pected renal tumor. However, in two patients renal failure 
developed following renal artery occlusion, and it was 
believed that the considerable amount of contrast media 
(350 cc of 76% renographic) used during the combined 
diagnostic and therapeutic angiographic procedures con-
tributed to the failures. Subsequently, the procedures have 
been performed at least 48 hours apart without any recur-
rence of this problem. 
Results 
Within several hours after embolization has been per-
formed, patients usually experience a "postinfarction" syn-
drome consist ing of pain, fever and gastrointestinal 
complaints (Table 1). Pain is usually localized to the affected 
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renal area and is directly related to the degree of infarction 
achieved by the procedure and inversely related to the 
amount of collateral and parasitic arterial supply to the 
tumor. Mild to moderate gastrointestinal symptoms of nau-
sea, vomiting and paralytic ileus frequently require re-
stricted oral intake and intravenous fluids for two or three 
days. In one patient, a gas-forming infection developed 
within the necrotic tumor mass and resulted in his death. 
Since then all patients wfth a positive urine culture, recent 
urinary tract infection, ora history of renal calculous disease 
have been placed on prophylactic antibiotics beginning the 
night before the procedure. 
TABLE 1 
Side Effects of Renal Artery Occlusion 
Type Percentage Mean Duration 
(Hours) 
Pain requiring injectable narcotics 88 57 (range: 24-144) 
Fever 85 83 (range: 24-264) 
Nausea and vomiting 78 41 (range: 24-144) 
Hypertension 5 — 
Sepsis 2 — 
To date, 75 patients wfth advanced renal carcinoma have 
been subjected to renal artery embolization (Table 11). In 14 
patients renal artery occlusion was done to facilitate re-
moval ofthe renal tumorswithin three days of nephrectomy. 
We believe that surgery was simplified in these cases 
because of the collapse of the engorged and fragile tumor 
vessels and the presence of edema induced by the infarction 
which tended to make tissue planes more distinct. Opera-
tive time and blood loss were also reduced. Although some 
investigators are now recommending its use in all surgical 
cases of renal carcinoma, there are inherent risks. These 
include escape of the embolization material into the sys-
temic circulation with occlusion of vessels resulting in 
arterial insufficiency, gangrene or paraplegia, as well as the 
morbidity and expense ofthe procedure. Consequently, we 
suggest that its use should be restricted to those with large 
and difficult tumors. Perhaps later we wi l l demonstrate that 
ft also plays a role in reducing local recurrences and 
subsequent metastases in patients with stage 11 and stage III 
disease by reducing intraoperative tumor dissemination. 
TABLE ll 
75 
61 
Total Patient Population 
With Metastases 
Infarction / nephrectomy / progestins 
Infarction / nephrectomy/other 
Infarction alone 
Without Metastases 
35 
3 
23 
Twenty-three patients wfth metastatic renal carcinoma un-
derwent renal artery embolization wfthout subsequent sur-
gical removal. All except one patient died of disease one 
week to nine months laterwfthout evidenceof a response. In 
the one patient who remained alive with disease, the 
procedure was performed for relief of local symptoms (pain, 
hematuria) which abated following the infarction. Based on 
these limited results, the procedure is not believed to alter 
survival in patients with metastatic disease if nephrectomy is 
not subsequently performed. 
Thirty-five patients with metastatic renal carcinoma have 
been treated with a combination of selective renal artery 
embolization, radical nephrectomy within five to seven 
days and medroxyprogesterone acetate (400 mg IM twice 
weekly). Twenty-eight patients are currently being evalu-
ated. Six have achieved a complete response with disap-
pearance of all known metastatic disease for periods 
ranging from 3 to 13 months, and six have had a partial 
response (greater than 50% reduction in the maximal 
diameters of all lesions). In two cases, the disease has 
stabilized. One patient has had a mixed response: while his 
pulmonary lesions disappeared, osseous metastases de-
veloped during the same period. 
Discussion 
The cause for these varied responses is as yet unexplained. 
Whether or not an altered immune response is associated 
wfth necrosis remains speculative. Swanson,* working our 
department, has suggested that the infarction may release a 
shower of tumor antigens into the c i rcu la t ion wh ich 
abruptly alters the relative concentrations of tumor antigens 
and anti-tumor specific antibodies and thereby affects the 
amount and solubility of circulating immune complexes. 
These alterations could reduce the effective level of serum-
blocking factors by clearing the complexes in the reticulo-
endothel ial system and / or reducing the ef f ic iency of 
the blocking factors so that a net improvement in cell-
mediated, tumor-specific immune response would result. 
Someof our patients who had the combination of infarction 
and nephrectomy showed an increased reactivity in skin 
tests to a battery of recall antigens. Also, in a few patients 
there was a change in the level of circulating immune 
complexes after infarction but before nephrectomy using an 
assay which measures binding to radioiodinated Clq. While 
these limited results suggest that the procedure is altering the 
cell-mediated immune response, the system is obviously 
very complex and considerable work needs to be com pleted 
before we can hope to understand the exact mechanisms. 
14 
* Personal Communication. 
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Conclusion 
Our early results with renal artery embolization are encour-
aging. At the present time, the procedure would appear to 
be indicated: 1) to facilitate surgical removal of large and 
difficult tumors; 2) to control local symptoms (pain, bleed-
ing, etc); and 3) as part of a planned therapeutic program 
consisting of infarction, nephrectomy and progestins for 
patients with minimal to moderate metastatic disease. While 
it does not offer permanent eradication of disease, the 
combination program does prolong survival for some pa-
tients. Consequently, until effective chemotherapeutic 
agents become available, its use should be considered. 
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